Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Guidant licenses rights to Micro Therapeutics technologies

Executive Summary

Guidant has agreed to invest up to $10mm in Micro Therapeutics' (devices for vascular disease) in the form of convertible debt, equity, and a credit line, in exchange for exclusive European rights to MT's Embolyx neurovascular technologies.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Contract
    • Includes Equity
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register